US Labeling for Eye Care: Ingredient Declaration, Warnings, and Common Mistakes
Proper labeling of eye care products for the US market is critical for compliance, consumer safety, and brand trust. Ingredient declaration accuracy, mandatory warnings, and awareness of common pitfalls can prevent costly recalls or enforcement actions. This guide outlines key requirements and practical sourcing tips for buyers and brand owners in the eye care category.
Core Labeling Requirements
Ingredient Declaration
- List ingredients in descending order of predominance by weight as required for cosmetics under 21 CFR 701.
- Use INCI (International Nomenclature of Cosmetic Ingredients) names rather than trade names.
- For OTC drug products (e.g., medicated eye drops), comply with Drug Facts panel requirements per FDA.
- Ensure readability: font size, contrast, and placement must meet FDA guidelines.
Mandatory Warnings
- Include specific eye safety warnings, such as “For external use only” or “Do not use in the eye” for cosmetics.
- For OTC products, add applicable contraindications, directions for safe usage, and first aid instructions.
- Address allergens or irritation risk (e.g., “Contains…” statements for potential sensitizers).
Common Mistakes to Avoid
- Incomplete ingredient listing – Missing minor constituents can lead to misbranding.
- Incorrect claims placement – Therapeutic claims on cosmetic labels can trigger OTC classification.
- Non-compliant font sizes – Text smaller than 1/16 inch height may fail legibility requirements.
- Failure to reconcile packaging vs. marketing claims – Website copy must match label claims to avoid misleading representation.
- Poor allergen disclosure – Not flagging known irritants violates consumer transparency expectations.
Practical Label Review Checklist
| Label Element | Requirement | Common Failure |
|---|---|---|
| Ingredient List | Descending order of weight, INCI names | Use of trade names or missing trace ingredients |
| Warnings | Specific to product type (cosmetic vs. OTC) | Generic warnings lacking required FDA language |
| Claims | Aligned to category, substantiated | Therapeutic claim on cosmetic SKU |
| Font & Visibility | Legible, minimum font size standards | Oversized label art reducing text space |
FAQ
Do cosmetic eye care products require a Drug Facts panel?
No, Drug Facts panels are only required for OTC drug products. Cosmetic eye care items must still follow 21 CFR 701 regarding ingredient declaration.
Can I list plant extracts using marketing names?
No. Use the correct INCI name to meet regulatory standards and improve ingredient transparency.
Are precautionary statements legally required for all eye care products?
They are mandatory for OTC drugs and strongly recommended for cosmetics that have any potential irritation risk.
What if my product is both soothing and marketed for redness relief?
Redness relief may be considered a drug claim in the US—consult with regulatory experts before finalizing the label.
Should allergen statements follow food labeling requirements?
Not exactly; cosmetics have different guidelines but should disclose known sensitizers to maintain consumer trust.